Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin

Dyslipidemia is a major risk factor in the initiation and progression of cardiovascular diseases such as atherosclerosis. Several pharmacological agents have been developed over the past 50 years which target various lipid components such as low density lipoprotein (LDL) cholesterol, triglyceride, a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pandian, Anbu, Arora, Anjali, Sperling, Laurence S, Khan, Bobby V
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605342/
https://ncbi.nlm.nih.gov/pubmed/19183748
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares